NanoVibronix Statistics
Total Valuation
NanoVibronix has a market cap or net worth of $895,970. The enterprise value is $4.18 million.
Important Dates
The last earnings date was Tuesday, May 20, 2025, after market close.
| Earnings Date | May 20, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
NanoVibronix has 759,297 shares outstanding. The number of shares has increased by 98.93% in one year.
| Current Share Class | 759,297 |
| Shares Outstanding | 759,297 |
| Shares Change (YoY) | +98.93% |
| Shares Change (QoQ) | +84.42% |
| Owned by Insiders (%) | 0.95% |
| Owned by Institutions (%) | 2.88% |
| Float | 629,414 |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.15 |
| Forward PS | n/a |
| PB Ratio | 0.02 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.57 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.47, with a Debt / Equity ratio of 0.11.
| Current Ratio | 0.47 |
| Quick Ratio | 0.12 |
| Debt / Equity | 0.11 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -26.30 |
Financial Efficiency
Return on equity (ROE) is -28.65% and return on invested capital (ROIC) is -14.08%.
| Return on Equity (ROE) | -28.65% |
| Return on Assets (ROA) | -12.08% |
| Return on Invested Capital (ROIC) | -14.08% |
| Return on Capital Employed (ROCE) | -13.55% |
| Revenue Per Employee | $85,871 |
| Profits Per Employee | -$181,032 |
| Employee Count | 31 |
| Asset Turnover | 0.11 |
| Inventory Turnover | 0.63 |
Taxes
In the past 12 months, NanoVibronix has paid $27,000 in taxes.
| Income Tax | 27,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -86.18% in the last 52 weeks. The beta is 2.04, so NanoVibronix's price volatility has been higher than the market average.
| Beta (5Y) | 2.04 |
| 52-Week Price Change | -86.18% |
| 50-Day Moving Average | 4.08 |
| 200-Day Moving Average | 5.59 |
| Relative Strength Index (RSI) | 28.00 |
| Average Volume (20 Days) | 2,441,177 |
Short Selling Information
The latest short interest is 118,953, so 15.67% of the outstanding shares have been sold short.
| Short Interest | 118,953 |
| Short Previous Month | 110,124 |
| Short % of Shares Out | 15.67% |
| Short % of Float | 18.90% |
| Short Ratio (days to cover) | 0.03 |
Income Statement
In the last 12 months, NanoVibronix had revenue of $2.66 million and -$5.61 million in losses. Loss per share was -$15.39.
| Revenue | 2.66M |
| Gross Profit | 1.21M |
| Operating Income | -4.87M |
| Pretax Income | -3.17M |
| Net Income | -5.61M |
| EBITDA | -4.85M |
| EBIT | -4.87M |
| Loss Per Share | -$15.39 |
Full Income StatementBalance Sheet
The company has $601,000 in cash and $3.92 million in debt, giving a net cash position of -$3.32 million or -$4.37 per share.
| Cash & Cash Equivalents | 601,000 |
| Total Debt | 3.92M |
| Net Cash | -3.32M |
| Net Cash Per Share | -$4.37 |
| Equity (Book Value) | 35.68M |
| Book Value Per Share | 48.60 |
| Working Capital | -4.34M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$3.28 million and capital expenditures -$7,000, giving a free cash flow of -$3.29 million.
| Operating Cash Flow | -3.28M |
| Capital Expenditures | -7,000 |
| Free Cash Flow | -3.29M |
| FCF Per Share | -$4.33 |
Full Cash Flow StatementMargins
Gross margin is 45.57%, with operating and profit margins of -182.79% and -210.82%.
| Gross Margin | 45.57% |
| Operating Margin | -182.79% |
| Pretax Margin | -209.80% |
| Profit Margin | -210.82% |
| EBITDA Margin | -182.09% |
| EBIT Margin | -182.79% |
| FCF Margin | n/a |